A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases (NCT06065449)

🧪 Interventions in This Study

• Radiation Therapy (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• M D Anderson Cancer Center — Houston, Texas

📞 Contact the Study Coordinator

Phone: (713) 563-2450

Email: qnnguyen@mdanderson.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Bone Metastases

• Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases — New York, New York
• Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer — Duarte, California
• Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases — Salt Lake City, Utah
• Post-Op Pain Control for Prophylactic Intramedullary Nailing. — St Louis, Missouri
• Registry for Bone Metastases — Basking Ridge, New Jersey

Explore by condition: All Bone Metastases clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.